Lingualcare, Inc. to Present at Medtech Insight and Windhover Information's ``Investment In Innovation (In3) WEST'' Conference, Feb. 23-24, Irvine.

IRVINE, Calif. -- Lingualcare, Inc. announced that it will be presenting on Feb. 23 at 11:50 a.m. at Medtech Insight and Windhover Information's "Investment In Innovation (In3) WEST: A Preview of Early-Stage Medical Technology Companies" Conference, Feb. 23-24, at the Hyatt Regency Irvine in Irvine.

Lingualcare is the developer of iBraces, the only 100-percent customized, invisible braces for orthodontic treatment of adolescents and adults. iBraces are placed behind the teeth and have each patient's unique prescription built into the braces to deliver efficient, effective treatment.

"Lingualcare is pleased to participate in the Investment In Innovation Conference and excited by the opportunity to introduce our company to leading investors and strategic partners from across the country," said Lea Nesbit, Lingualcare CEO. "Orthodontics is a $12 billion fee-for-service healthcare segment, and there is a tremendous opportunity for products like iBraces that combine great aesthetics, patient comfort and excellent treatment results. We are looking for an investment partner who will share our passion and commitment to improving the patient experience."

More than 3 million adolescents and adults seek orthodontic treatment each year. A recent survey by the American Academy of Cosmetic Dentistry found that 99.7% of adults believe that an attractive smile is an important social asset and that 74% of adults believe that an unattractive smile can hurt your chance of career success. The same survey found that 50% are currently unhappy with their smile. For those reasons, more and more adults are seeking orthodontic treatment.

"There is an untapped market of adult as well as teen patients who desire corrective orthodontic therapy but will not initiate due to the unsightly appearance of orthodontic appliances," said Dr. Neil Warshawsky, an orthodontist practicing in Chicago. "iBraces transcend this barrier by not only treating these patients in comfortable, cosmetic appliances, but they do it in a manner that people do not even know that it is occurring."

"The American Association of Orthodontists estimates that 75 million Americans could benefit from orthodontic treatment," said Nesbit. "We believe that there are millions of adults who would like to have straight teeth but who will not wear braces. iBraces give orthodontists a new tool to grow their practices and reach a whole new group of patients."

"Almost every person we treat with iBraces will refer not 1 but 2 patients in as a result of their experience, and that is before the cases are even completed. As an orthodontist, this excites me as I know this sets me apart and gives our practice huge potential for future growth," added Warshawsky.

Lingualcare, Inc. is a dental technology company focused on the mass customization of orthodontic appliances. They are the developer of iBraces, North America's first complete, customized lingual (behind the teeth) orthodontic system for teens and adults. Founded in October 2002, Lingualcare serves orthodontists, dental professionals and consumers with excellent orthodontic products, training, services and support. iBraces were first used to treat patients in Europe in 2002 and in the United States in 2003. To date more than 6,000 patients worldwide have been treated with iBraces. Lingualcare is a privately held company based in Dallas.

A division of Windhover Information Inc., Medtech Insight is the leading provider of business information and market intelligence for the medical technology marketplace. In3 WEST is Medtech Insight's 20th investment and partnering event to date. To register to attend or for more information on Medtech Insight, please call Kristy Grimes at 480-985-9512 or 888-202-5939 toll-free in the U.S., e-mail [e-mail], or visit www.medtechinsight.com.